Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Update: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) [Phase 3]
Phase 3 clinical trial update evaluating durvalumab in combination with chemotherapy as first-line treatment for advanced biliary tract canc…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers [Phase 1, Phase 2]
The document describes an ongoing Phase 1/2 trial evaluating tivozanib for biliary tract cancers and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
AstraZeneca is conducting a multicenter, non-interventional study in Chinese pan-tumor patients to assess concordance of HER2 IHC testing ac…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) [Phase 3]
Phase 3 trial evaluating durvalumab in combination with chemotherapy as first-line treatment for advanced biliary tract cancer. The study is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients
A completed clinical study from AstraZeneca evaluating the relationship between biliary complications and treatment duration in unresectable…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer [Phase 2]
A Phase 2 study evaluating novel immunomodulators as both monotherapy and in combination with anticancer agents for advanced hepatobiliary c…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating HX009 plus IN10018 with or without standard chemotherapy for advanced solid tumors, including biliary tr…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer [Phase 3]
A Phase 3 trial evaluating trastuzumab deruxtecan-based therapy with rilvegostomig versus standard of care for advanced HER2-expressing bili…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II clinical trial is evaluating iparomlimab and tuvonralimab (QL1706) in combination with albumin-bound paclitaxel and lenvatinib as…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]
An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and prelimi…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer [Phase 3]
Phase 3 trial update for D07001 softgel-capsules in combination with capecitabine in advanced biliary tract cancer; the study is not yet rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 clinical trial evaluating chemotherapy with or without binimetinib for advanced biliary tract cancers. The study is currently active…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II randomized trial comparing SLOG versus GC in locally advanced or metastatic biliary tract cancer has completed.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer [Phase 3]
This clinical trial update describes a Phase 3 study comparing Nanvuranlat to physician's best choice in adults with biliary tract cancer; r…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer [NA]
A clinical trial evaluating hepatic arterial infusion chemotherapy plus systemic therapy as a de-escalation strategy for biliary tract cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TQB2102 for injection is underway for HER2-positive biliary tract cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER
A comprehensive biomarker evaluation study in biliary tract cancer sponsored by MedSIR is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer [Phase 1]
Phase 1 trial evaluating Emavusertib (CA-4948) in combination with cisplatin, gemcitabine, and durvalumab in untreated advanced or metastati…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC [Phase 2]
Phase 2 study of RP2 in combination with second-line therapy for locally advanced or metastatic hepatocellular carcinoma and biliary tract c…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy [Phase 2]
A Phase 2 clinical trial evaluates trastuzumab in combination with serplulimab and chemotherapy for HER2-overexpressing unresectable locally…